Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

  

Gerald Chan, DSc.

Gerald ChanCo-Founder, Morningside
Dr. Chan co-founded Morningside, a diversified investment group engaged primarily in private equity and venture capital investments in North America, Asia and Europe. Morningside commenced investing in China in 1992 and remains active in China’s internet, media and life sciences sectors. Dr. Chan is a director of publicly listed Hang Lung Group Limited, a Hong Kong property development company, and serves on the boards of several private biotechnology companies, including Serica, Inc., Critical Biologics Corporation, CellCentric, Ltd., Inimex Pharmaceuticals, Inc., Green Biologics, Inc., Stealth Peptides Inc., and Vaccine Technologies Inc. Dr. Chan is a trustee of Fudan University in Shanghai and sits on the advisory boards of the Johns Hopkins University - Nanjing University Center for Chinese and American Studies, The Institute of Mathematical Science of the Chinese University of Hong Kong, the International Society of Stem Cell Research Global Advisory Council, Cold Spring Harbor Conferences Asia, Harvard China Fund, and the Physical Sciences Visiting Committee of UCLA.
 

Dr. Chan received his BS and MS degrees in Engineering from UCLA, and a Master of Science degree in Medical Radiological Physics and a Doctor of Science degree in Radiation Biology from Harvard University. He completed his post-doctoral training at the Dana Farber Cancer Institute.